New Delhi, Nov. 9 -- Divi's Laboratories shares rallied over 6% on Monday, 9 November, hitting a fresh 52-week high for the second consecutive session, after surging more than 8% during Sunday's special Muhurat Trading session. Strong second-quarter earnings for FY27 and upbeat brokerage commentary on the company's growth prospects, particularly in its custom synthesis and peptides businesses, have strengthened investor sentiment.

The pharmaceutical company's consolidated net profit jumped nearly 64% year-on-year (YoY) to Rs.1,127 crore in the September quarter of FY27, compared with the corresponding period last year. Revenue from operations increased over 35% YoY to Rs.3,676 crore during Q2 FY27.

Divi's Laboratories reported a foreign...